SCH-23390
Appearance
| Names | |
|---|---|
| IUPAC name
7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI |
|
| ChEMBL |
|
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C17H18ClNO | |
| Molar mass | 287.78 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
SCH-23390, also known as halobenzazepine, is a synthetic compound that acts as a dopamine D1 receptor antagonist with either minimal or negligible effects on the D2 receptor.[1]
In a 1990 study in rats SCH-23390 offered significant protection from death in dextroamphetamine overdose, without providing protection from death by methamphetamine overdose. The compound provided significant protection from cocaine overdose in rats only at the lowest dose tested in the measurement series. This suggested that dextroamphetamine and methamphetamine at high (lethal) doses have different mechanisms of toxicity in rats.[2]
In addition to its actions as a dopamine D1 receptor antagonist, SCH-23390 has been found to act as a GIRK blocker.[3]
See also
[edit]- Substituted 3-benzazepine
- Berupipam (NNC 22-0010)
- Ecopipam (SCH-39166)
- NNC 01-0687 (ADX-10061)
- Odapipam (NNC 01-0756)
References
[edit]- ↑ Bourne, J. A. (December 2001). "SCH 23390: The First Selective Dopamine D 1 -Like Receptor Antagonist". CNS Drug Reviews. 7 (4): 399–414. doi:10.1111/j.1527-3458.2001.tb00207.x. PMC 6741643. PMID 11830757.
- ↑ Derlet, R. W.; Albertson, T. E.; Rice, P. (1990). "The Effect of SCH 23390 Against Toxic Doses of Cocaine, d-Amphetamine and Methamphetamine". Life Sciences. 47 (9): 821–827. doi:10.1016/0024-3205(90)90555-6. PMID 2215083.
- ↑ Kuzhikandathil EV, Oxford GS (July 2002). "Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels". Mol Pharmacol. 62 (1): 119–126. doi:10.1124/mol.62.1.119. PMID 12065762.
